| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18792548 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 101 journal articles in the PubMed database | Email to a friend | | |
| Leyden JJ, Wortzman M
A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring. [Journal Article]
Cutis 2008 Aug; 82(2):151-6.
Abstract | Full Citation | Find Related Articles | | Richter JR, Förström LR, Kiistala UO, et al.
Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Eur Acad Dermatol Venereol 1998 Nov; 11(3):227-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Schlessinger J, Menter A, Gold M, et al.
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. [Journal Article]
J Drugs Dermatol 2007 Jun; 6(6):607-15.
Abstract | Full Citation | Find Related Articles | | Berger R, Rizer R, Barba A, et al.
Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: A 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. [Journal Article]
Clin Ther 2007 Jun; 29(6):1086-97.
Abstract | Full Citation | | Cunliffe WJ, Holland KT, Bojar R, et al.
A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2002 Jul; 24(7):1117-33.
Abstract | Full Citation | Find Related Articles | | Zouboulis CC, Derumeaux L, Decroix J, et al.
A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Br J Dermatol 2000 Sep; 143(3):498-505.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tanghetti E, Dhawan S, Torok H, et al.
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. [Journal Article]
Dermatol Online J 2007; 13(3):1.
Abstract | Full Citation | | Leyden JJ, Berger RS, Dunlap FE, et al.
Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Clin Dermatol 2001; 2(1):33-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bowman S, Gold M, Nasir A, et al.
Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Drugs Dermatol 2005 Sep-Oct; 4(5):611-8.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
